Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation

AIMS: To examine whether CYP3A4-metabolizing statin use modified the association between clopidogrel use and major adverse cardiovascular events (MACE) after coronary stent implantation, using time-varying drug exposure ascertainment. METHODS: We conducted this population-based cohort study in Weste...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Schmidt, Morten, Johansen, Martin B, Maeng, Michael, Kaltoft, Anne, Jensen, Lisette O, Tilsted, Hans-Henrik, Bøtker, Hans E, Baron, John A, Sørensen, Henrik Toft
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Science Inc 2012
Soggetti:
Drug Safety
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3394141/
https://ncbi.nlm.nih.gov/pubmed/22243420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2012.04169.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi